Standards & Regulation

Jun 27, 2017
By Pharmaceutical Technology Editors
The agency sent a warning letter to Raritan Pharmaceuticals, Inc. after an inspection found quality testing and misbranding violations.
Jun 27, 2017
By Pharmaceutical Technology Editors
The agency announced it is taking steps to increase competition within the prescription drug market.
Jun 26, 2017
By Pharmaceutical Technology Editors
Fagron Sterile Services has voluntarily recalled three lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level.
Jun 23, 2017
By Pharmaceutical Technology Editors
The agency recommended approval of treatments for hepatitis C, cancer, multiple sclerosis, and arthritis.
Jun 21, 2017
By Pharmaceutical Technology Editors
FDA Commissioner Scott Gottlieb announced the agency will hold a public meeting on drug competition as part of its Drug Competition Action Plan.
Jun 16, 2017
By Pharmaceutical Technology Editors
The agency’s management board discussed plans for the relocation of EMA at its June 2017 meeting.
Jun 15, 2017
By Pharmaceutical Technology Editors
A consent decree of permanent injunction was entered between the United States and the two companies due to unapproved, mislabeled, and adulterated drugs.
Jun 15, 2017
Congressional measures lack the support to move forward.
Jun 14, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to drug compounder DCA, Inc. dba Beacon Prescriptions for failing to ensure sanitary conditions.
Jun 14, 2017
By Pharmaceutical Technology Editors
FDA Commissioner Scott Gottlieb announced the July meeting as part of his commitment to address opioid abuse.
native1_300x100
lorem ipsum